Summary
![]() |
Reinhold Horlacher PhD
CSO and managing director, trenzyme, Reinhold has a long track record as a protein production and cell line development specialist. With 20 years of expertise, trenzyme is the service provider for highly customized cell line development and recombinant protein production from development to GMP-compliant production. Reinhol’s moto: finding the ideal solution for the individual requirements of trenzymes clients.
|
|
![]() |
Alengo Nyamay’antu, PhD
Alengo is the Scientific Communication Specialist at Polyplus-transfection. Alengo is a globe trotter specialized in Protein Biochemistry and Biomedecine that is particularly keen on exchanging and discussing Science. |
• trenzyme, its know-how and its mission
• Off the shelf recombinant SARS-CoV-2 proteins.
• Overcoming production of spike proteins challenges
• Critical parameters for protein production platform set-up
• XPOVAX, an innovative COVID-19 vaccine strategy
Find trenzyme presentation at PEGS EU 2020 Virtual congress below: